Literature DB >> 25590614

The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo.

Jin Qiu1, Pamela Smith2, Leah Leahy2, David A Thorley-Lawson1.   

Abstract

The human herpes virus Epstein-Barr virus (EBV) latently infects and drives the proliferation of B lymphocytes in vitro and is associated with several forms of lymphoma and carcinoma in vivo. The virus encodes ~30 miRNAs in the BART region, the function of most of which remains elusive. Here we have used a new mouse xenograft model of EBV driven carcinomagenesis to demonstrate that the BART miRNAs potentiate tumor growth and development in vivo. No effect was seen on invasion or metastasis, and the growth promoting activity was not seen in vitro. In vivo tumor growth was not associated with the expression of specific BART miRNAs but with up regulation of all the BART miRNAs, consistent with previous observations that all the BART miRNAs are highly expressed in all of the EBV associated cancers. Based on these observations, we suggest that deregulated expression of the BART miRNAs potentiates tumor growth and represents a general mechanism behind EBV associated oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25590614      PMCID: PMC4295875          DOI: 10.1371/journal.ppat.1004561

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  50 in total

1.  Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells.

Authors:  Donna Hochberg; Tatyana Souza; Michelle Catalina; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 2.  Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

Authors:  David A Thorley-Lawson; Andrew Gross
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

3.  EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.

Authors:  Kasandra J Riley; Gabrielle S Rabinowitz; Therese A Yario; Joseph M Luna; Robert B Darnell; Joan A Steitz
Journal:  EMBO J       Date:  2012-03-30       Impact factor: 11.598

4.  An orthotopic model of metastatic nasopharyngeal carcinoma and its application in elucidating a therapeutic target that inhibits metastasis.

Authors:  Pamela A Smith; David Merritt; Leah Barr; David A Thorley-Lawson
Journal:  Genes Cancer       Date:  2011-11

5.  A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses.

Authors:  Adam Grundhoff; Christopher S Sullivan; Don Ganem
Journal:  RNA       Date:  2006-03-15       Impact factor: 4.942

6.  Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.

Authors:  Naohiro Wakisaka; Shigeyuki Murono; Tomokazu Yoshizaki; Mitsuru Furukawa; Joseph S Pagano
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

7.  Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype.

Authors:  J Chodosh; V P Holder; Y J Gan; A Belgaumi; J Sample; J W Sixbey
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

8.  An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.

Authors:  E S Robertson; B Tomkinson; E Kieff
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

9.  Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.

Authors:  N Shimizu; A Tanabe-Tochikura; Y Kuroiwa; K Takada
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  Epstein-Barr virus maintains lymphomas via its miRNAs.

Authors:  D T Vereide; E Seto; Y-F Chiu; M Hayes; T Tagawa; A Grundhoff; W Hammerschmidt; B Sugden
Journal:  Oncogene       Date:  2013-03-18       Impact factor: 9.867

View more
  37 in total

1.  Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.

Authors:  Aron R Marquitz; Anuja Mathur; Rachel Hood Edwards; Nancy Raab-Traub
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Pathogenesis: Infections causing gastric cancer.

Authors:  Paul Farrell
Journal:  Nat Microbiol       Date:  2016-03-29       Impact factor: 17.745

Review 3.  The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  Chi Man Tsang; Sai Wah Tsao
Journal:  Virol Sin       Date:  2015-04-21       Impact factor: 4.327

Review 4.  Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers.

Authors:  Deilson Elgui de Oliveira; Bárbara G Müller-Coan; Joseph S Pagano
Journal:  Trends Microbiol       Date:  2016-04-07       Impact factor: 17.079

Review 5.  Epstein-Barr virus: more than 50 years old and still providing surprises.

Authors:  Lawrence S Young; Lee Fah Yap; Paul G Murray
Journal:  Nat Rev Cancer       Date:  2016-09-30       Impact factor: 60.716

Review 6.  Epstein-Barr virus infection and nasopharyngeal carcinoma.

Authors:  Sai Wah Tsao; Chi Man Tsang; Kwok Wai Lo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

Review 7.  Roles of Non-coding RNAs During Herpesvirus Infection.

Authors:  Meaghan H Hancock; Rebecca L Skalsky
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

8.  EBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape.

Authors:  Nathan Ungerleider; Whitney Bullard; Mehmet Kara; Xia Wang; Claire Roberts; Rolf Renne; Scott Tibbetts; Erik K Flemington
Journal:  PLoS Pathog       Date:  2021-05-06       Impact factor: 6.823

Review 9.  Deletion of Viral microRNAs in the Oncogenesis of Epstein-Barr Virus-Associated Lymphoma.

Authors:  Hiroshi Kimura; Yusuke Okuno; Yoshitaka Sato; Takahiro Watanabe; Takayuki Murata
Journal:  Front Microbiol       Date:  2021-07-08       Impact factor: 5.640

10.  The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.

Authors:  Mohsen Navari; Maryam Etebari; Giulia De Falco; Maria R Ambrosio; Davide Gibellini; Lorenzo Leoncini; Pier Paolo Piccaluga
Journal:  Front Microbiol       Date:  2015-06-10       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.